Knight M J, Riffkin C D, Muscat A M, Ashley D M, Hawkins C J
Department of Haematology and Oncology, Royal Children's Hospital, Parkville, Victoria, Australia 3052.
Oncogene. 2001 Sep 13;20(41):5789-98. doi: 10.1038/sj.onc.1204810.
FasL and TNF-related apoptosis-inducing ligand (TRAIL) belong to a subgroup of the TNF superfamily which induce apoptosis by binding to their death domain containing receptors. In the present study we have utilized a panel of seven cell lines derived from human malignant gliomas to characterize molecular pathways through which FasL and TRAIL induce apoptosis in sensitive glioma cells and the mechanisms of resistance in cell lines which survive the death stimuli. Our findings indicate that FADD and Caspase-8 are essential for FasL and TRAIL mediated apoptosis in glioma cells. One sensitive cell line (D270) can be protected from FasL and TRAIL induced death by anti-apoptotic Bcl-2 family members while another (D645) cannot, implying that these lines may represent glioma examples of type II and type I cells respectively. For the first time we demonstrate resistance to FasL but not to TRAIL within the one glioma cell line. Furthermore, we report distinct mechanisms of resistance within different glioma lines, including downregulation of Caspase-8 in U373MG. Cycloheximide sensitized four of the resistant cell lines suggesting the presence of labile inhibitors. None of the known apoptosis inhibitors examined accounted for the observed resistance, suggesting novel inhibitors may exist in glioma cells.
FasL和肿瘤坏死因子相关凋亡诱导配体(TRAIL)属于肿瘤坏死因子超家族的一个亚组,它们通过与含死亡结构域的受体结合来诱导细胞凋亡。在本研究中,我们利用了一组源自人类恶性胶质瘤的七种细胞系,以表征FasL和TRAIL在敏感胶质瘤细胞中诱导细胞凋亡的分子途径,以及在死亡刺激下存活的细胞系中的耐药机制。我们的研究结果表明,FADD和半胱天冬酶-8对于胶质瘤细胞中FasL和TRAIL介导的细胞凋亡至关重要。一种敏感细胞系(D270)可被抗凋亡Bcl-2家族成员保护免受FasL和TRAIL诱导的死亡,而另一种(D645)则不能,这意味着这些细胞系可能分别代表II型和I型细胞的胶质瘤实例。我们首次在一种胶质瘤细胞系中证明了对FasL的耐药性,但对TRAIL没有耐药性。此外,我们报告了不同胶质瘤细胞系中的不同耐药机制,包括U373MG中半胱天冬酶-8的下调。放线菌酮使四种耐药细胞系敏感,表明存在不稳定的抑制剂。所检测的已知凋亡抑制剂均不能解释所观察到的耐药性,这表明胶质瘤细胞中可能存在新型抑制剂。